Aradigm
HomeAboutProductsTechnologiesInvestorsCareers
Download Library

Investor Relations

Press Releases

Events & Presentations

Corporate Governance

Financial Information

Stock Information

Contact Us


Quickly sort and find the exact file you need here. Send the files directly into your Shareholder Briefcase or read and right click "save target as" individual files.

Title Date Type Size  
2017 World BE Conference Inhaled Liposomal Ciprofloxacin in Patients With Non-Cystic Fibrosis Bronchiectasis and Chronic Pseudomonas aeruginosa Infection: Pharmacokinetics of Once-Daily Inhaled ARD-3150   PDF 554.9 KB Add to Briefcase
2017 ISAM Conference Inhaled Liposomal Ciprofloxacin for the Prevention and Treatment of Severe Intracellular Lung Infections   PDF 788.6 KB Add to Briefcase
2017 World BE Conference Microbiological Results From Two Parallel, Randomized, Double-blind, Placebo-Controlled Phase III Trials (ORBIT-3 and ORBIT-4) of the Inhaled Antibiotic ARD-3150 in Patients With Non-Cystic Fibrosis Bronchiectasis and Chronic Pseudomonas aeruginosa Infection   PDF 2.7 MB Add to Briefcase
2017 ISAM Conference Inhaled Liposomal Ciprofloxacin in Patients With Non-cystic Fibrosis Bronchiectasis and Chronic Pseudomonas aeruginosa Lung Infection   PDF 233.8 KB Add to Briefcase
2017 World BE Conference Inhaled Liposomal Ciprofloxacin in Patients With Bronchiectasis and Chronic Pseudomonas aeruginosa Infection: Results From Two Parallel Phase III Trials (ORBIT-3 and ORBIT-4)   PDF 232.7 KB Add to Briefcase
2015 Annual Report   HTML file N/A  
Intensive Therapy With Inhaled Insulin via the AERx Insulin Diabetes Management System   PDF 101.9 KB Add to Briefcase
2016 ATS Conference ORBIT-3 and ORBIT-4: Design of a Phase 3 Program to Investigate Safety and Efficacy of Pulmaquin® in Non-Cystic Fibrosis Bronchiectasis (NCFBE) Patients Chronically Colonized with Pseudomonas Aeruginosa (PA)   PDF 241.3 KB Add to Briefcase
2016 ATS Conference Liposome-Ciprofloxacin inhibits Mycobacterium avium subsp hominissuis (MAH) microaggregate formation in dose and time-related manner   PDF 517.3 KB Add to Briefcase
2014 Annual Report   HTML file N/A  
Showing 1-10 of 28 Page: 1 2 3  Next 10
Add to Briefcase = add file to Briefcase
CONTACT NEWS & EVENTS LEGAL SITE MAP ©2017 Aradigm Corporation. All Rights Reserved.